A Study of NT 201 in Adults With Moderate to Severe Platysma Prominence in the United States

Inclusion Criteria:

• Presence of four (medial and lateral, left and right) platysmal bands assessed atscreening and baseline.

• A score of Grade 3 ('moderate') or Grade 4 ('severe') on the MAPS-D at maximumcontraction by the investigator and participant.

Exclusion Criteria:

• Hypersensitivity or a history of allergic reaction to botulinum toxin of anyserotype or any of their formulation ingredients.

• Any medical condition that may put the participant at increased risk with exposureto botulinum toxin of any serotype, or any disorders that might interfere withneuromuscular function.

• Any serious disease or disorder that could interfere with the safe completion oftreatment or with study outcome assessments, or compromise participant safety.

• Botulinum toxin treatment in the face (below the lower orbital rim), jawline, orneck within the last seven months.

• History of lower face surgery, neck or chest surgery, and aesthetic procedures inthe past 12 months, and/or orthodontic procedures in the past 6 months.

• Planned surgery or aesthetic procedures to the lower face, neck, or chest during thestudy period.

• Anticipated need for treatment with botulinum toxin of any serotype for anyindication during the study (other than study products).